ATE540684T1 - Zubereitung und verfahren zur regulierung und aufrechterhaltung der vaginalen bakterienflora und der normalen acidität in der vagina - Google Patents

Zubereitung und verfahren zur regulierung und aufrechterhaltung der vaginalen bakterienflora und der normalen acidität in der vagina

Info

Publication number
ATE540684T1
ATE540684T1 AT06741747T AT06741747T ATE540684T1 AT E540684 T1 ATE540684 T1 AT E540684T1 AT 06741747 T AT06741747 T AT 06741747T AT 06741747 T AT06741747 T AT 06741747T AT E540684 T1 ATE540684 T1 AT E540684T1
Authority
AT
Austria
Prior art keywords
vaginal
vagina
regulating
preparation
bacterial flora
Prior art date
Application number
AT06741747T
Other languages
English (en)
Inventor
Zhongming Zeng
Ruyun Zhou
Original Assignee
Shenzhen Phlora Biotechnology Ltd
Hk Phlora Health Sci & Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Phlora Biotechnology Ltd, Hk Phlora Health Sci & Tech Ltd filed Critical Shenzhen Phlora Biotechnology Ltd
Application granted granted Critical
Publication of ATE540684T1 publication Critical patent/ATE540684T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06741747T 2005-04-27 2006-04-27 Zubereitung und verfahren zur regulierung und aufrechterhaltung der vaginalen bakterienflora und der normalen acidität in der vagina ATE540684T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200510070307 2005-04-27
PCT/CN2006/000826 WO2006114061A1 (fr) 2005-04-27 2006-04-27 Composition et procédé de régulation et de maintien de la flore bactérienne vaginale et de l'acidité normale dans le vagin

Publications (1)

Publication Number Publication Date
ATE540684T1 true ATE540684T1 (de) 2012-01-15

Family

ID=37214419

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06741747T ATE540684T1 (de) 2005-04-27 2006-04-27 Zubereitung und verfahren zur regulierung und aufrechterhaltung der vaginalen bakterienflora und der normalen acidität in der vagina

Country Status (9)

Country Link
US (2) US20080193428A1 (de)
EP (1) EP1911454B1 (de)
JP (1) JP5065246B2 (de)
CN (1) CN101175503B (de)
AT (1) ATE540684T1 (de)
BR (1) BRPI0612968A2 (de)
CA (1) CA2609754C (de)
RU (1) RU2409368C2 (de)
WO (1) WO2006114061A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1287914B1 (de) * 1997-12-12 2004-03-31 Mitsubishi Heavy Industries, Ltd. Walzanlage und Walzvorrichtung
WO2008060200A1 (en) 2006-11-17 2008-05-22 Sca Hygiene Products Ab Sanitary article comprising a microbe-inhibiting composition
AU2006350772C1 (en) * 2006-11-17 2013-05-23 Essity Hygiene And Health Aktiebolag Hygiene tissue comprising a microbe-inhibiting composition
US20090185995A1 (en) * 2008-01-18 2009-07-23 Stacy Vochecowicz Lubricious, non-tacky personal lubricant
IT1398279B1 (it) * 2009-06-25 2013-02-22 Bsd Formulazioni farmaceutiche per uso intravaginale nella prevenzione e terapia delle vulvo vaginiti e nel ripristino della fisiologia vaginale
CN102470117B (zh) * 2009-10-08 2014-07-30 曾忠铭 一种以苯甲酸和有机酸防腐剂相联合作为有效成分的组合物及其用途
KR101133723B1 (ko) * 2009-10-19 2012-04-09 최원석 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도
RU2444370C1 (ru) * 2010-06-30 2012-03-10 Владимир Александрович Мельников Пребиотик, стимулирующий рост вагинальной лактофлоры
US9011909B2 (en) * 2010-09-03 2015-04-21 Wisconsin Pharmacal Company, Llc Prebiotic suppositories
KR101470282B1 (ko) * 2013-10-01 2014-12-05 최원석 소금 및 당의 조합물을 유효성분으로 함유하는 질이완증 또는 질건조증 예방 및 치료용 약학 조성물 및 이의 용도
CA2942424C (en) 2014-03-13 2019-12-31 Singapore Ze&Z International Pte. Ltd. Vaginal composition and use thereof
RU2563232C1 (ru) * 2014-04-01 2015-09-20 Общество с ограниченной ответственностью "КОЛЕТЕКС" Способ получения лечебного гидрогеля
US10016361B2 (en) 2014-10-24 2018-07-10 Francoise Farron PH change in the vagina as a contraceptive
CN105055439B (zh) * 2015-08-21 2018-04-13 叶元康 一种阴道微生态维护、保健和防治制剂及制备方法与应用
CN108135919B (zh) * 2015-09-29 2024-06-18 金伯利-克拉克环球有限公司 用于维持乳杆菌属优势的组合物
MX2018002533A (es) 2015-09-29 2018-06-27 Kimberly Clark Co Composicion sinergica para el mantenimiento de un equilibrio saludable de la microflora.
EP3442501A1 (de) 2016-04-15 2019-02-20 Fairhaven Health, LLC Zusammensetzungen und verfahren zur aufrechterhaltung oder erhöhung der homöostase oder funktion des unteren weiblichen fortpflanzungstraktes
EP3272333A1 (de) 2016-07-22 2018-01-24 Chemo Research, S.L. Vaginale zubereitung enthaltend eine kombination von östrogen und vitamin d
CN107661502A (zh) * 2016-07-27 2018-02-06 厦门恩成制药有限公司 低聚糖在药物制剂中的应用
BR112019015239A2 (pt) 2017-02-28 2020-04-14 Kimberly Clark Co composição, e, método para manter um equilíbrio de microflora saudável na área urogenital de um paciente com necessidade do mesmo.
US12011469B2 (en) * 2017-05-23 2024-06-18 Vireo Systems, Inc. Parenteral delivery device and methods of use
CA3086082A1 (en) * 2017-12-18 2019-06-27 Ansella Therapeutics, Inc. Compositions and methods for preventing and treating conditions
TWI754126B (zh) * 2018-07-19 2022-02-01 大江生醫股份有限公司 益生質組合物用於改善女性陰道內的菌相的用途及外用衛生用品
EP3894018A4 (de) * 2018-12-11 2022-11-02 Glyciome, LLC Topische, isotonische zusammensetzungen zur genitalverwendung
CN109646394A (zh) * 2019-01-16 2019-04-19 江西鼎中科技有限公司 一种治疗细菌性阴道炎的蔗糖凝胶及其应用
RU2703260C1 (ru) * 2019-06-11 2019-10-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Южно-Уральский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ЮУГМУ Минздрава России) Способ дифференцированной коррекции биоценоза влагалища при цервиковагинальных инфекциях у женщин в i триместре беременности
WO2021133697A1 (en) * 2019-12-23 2021-07-01 Glyciome, Llc Microbiome optimization
US12083304B2 (en) 2019-12-23 2024-09-10 Glyciome, Llc Kits for topical, isotonic compositions
CN111175103B (zh) * 2020-01-16 2023-07-04 江西业力医疗器械有限公司 一种真菌性阴道炎荧光检测的白带样本前处理液及其制备方法
EP4161531A1 (de) * 2020-06-09 2023-04-12 G. Pohl-Boskamp GmbH & Co. KG Zusammensetzungen zur prophylaxe und behandlung von harnwegsinfektionen und zur kosmetischen anwendung
CA3184420A1 (en) 2020-06-30 2022-01-06 Mark C. Faulkner Compositions and methods for treatment of vaginal infections
CN114306108A (zh) * 2022-01-17 2022-04-12 北京图灵微研生物科技有限公司 一种平衡妇科微生态菌群结构的护理剂
CN115006697A (zh) * 2022-05-14 2022-09-06 河南沃迈生物科技有限公司 一种医用妇科凝胶敷料微生态制剂装置及制作方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8603338D0 (sv) * 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan
AU7176994A (en) * 1993-06-25 1995-01-17 Ibah, Inc. Taste-masked acetaminophen suspensions and methods of making the same
AU1854297A (en) * 1996-02-14 1997-09-02 Procter & Gamble Company, The Urogenital and intestinal disorder compositions comprising substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
WO1999026636A1 (fr) * 1997-11-24 1999-06-03 Zhongming Zeng Formulation pharmaceutique de stimulation de la croissance de bacilles gram positifs et d'augmentation de l'acidite du vagin et leur utilisation
US6849256B1 (en) * 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
HU230315B1 (hu) * 2000-03-07 2016-01-28 Rush-Presbyterian-St. Luke's Medical Center Összetételek és eljárások patogén mikrobák és spermatozoák csapdázására
US6964949B2 (en) * 2000-05-24 2005-11-15 Shanghai Jiao Da Onlly Co., Ltd. Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
WO2002030355A2 (en) * 2000-10-11 2002-04-18 Laura Kragie Composition and method of alleviating adverse side effects and/or enhancing efficacy of agents that inhibit aromatase
US6899890B2 (en) 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
US7456207B2 (en) * 2003-09-25 2008-11-25 Teva Pharmaceuticals Usa, Inc. Vaginal pharmaceutical compositions and methods for preparing them
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections

Also Published As

Publication number Publication date
RU2409368C2 (ru) 2011-01-20
CN101175503A (zh) 2008-05-07
RU2007143977A (ru) 2009-06-10
EP1911454B1 (de) 2012-01-11
CN101175503B (zh) 2012-12-12
WO2006114061A1 (fr) 2006-11-02
EP1911454A1 (de) 2008-04-16
US8586549B2 (en) 2013-11-19
BRPI0612968A2 (pt) 2010-12-14
EP1911454A4 (de) 2009-07-29
CA2609754C (en) 2012-01-10
JP5065246B2 (ja) 2012-10-31
US20120263667A1 (en) 2012-10-18
JP2008539176A (ja) 2008-11-13
US20080193428A1 (en) 2008-08-14
CA2609754A1 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
ATE540684T1 (de) Zubereitung und verfahren zur regulierung und aufrechterhaltung der vaginalen bakterienflora und der normalen acidität in der vagina
BR0215517A (pt) Composição anti-séptica, e, métodos para desinfetar tecido e para produzir uma composição anti-séptica
TW200616541A (en) Benzoyl-substituted serineamides
BR0108734A (pt) Composições antimicrobiais ácidas para tratar alimento e superfìcies de contato do alimento e métodos para uso das mesmas
WO2010033800A3 (en) Stable tetracycline aqueous formulations
ATE482726T1 (de) Neuartiges mittel zur freisetzung von wirkstoffen in dressings mit mindestens einer fettigen substanz
NO20071042L (no) 5-substituerte 2-fenylaminobenzamider som MEK-inhibitorer
UA81568C2 (en) Benzoyl-substituted phenylalanine amides, methods and intermediate products for the production thereof, herbicidal composition and method for controlling undesired plants
WO2008073933A3 (en) 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
WO2007089473A8 (en) Thickened fluid composition comprising chlorine dioxide
WO2007093539A3 (de) Benzoylsubstituierte alanine
BRPI0508117A (pt) composições de bebida ácida
WO2010120368A3 (en) Stabilization of radiopharmaceutical compositions using ascorbic acid
UA102236C2 (uk) Похідні еритропоетин-міметичного пептиду та їх фармацевтичні солі, їх одержання і застосування
WO2007018622A3 (en) Vaginal treatment composition
MX2007006861A (es) Composiciones que tienen alta eficacia antiviral y antibacterial.
MY146622A (en) N-phenylpyrazole derivatives as pesticides
MX2009007265A (es) Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion.
PL1855692T3 (pl) Kompozycje do leczenia chorób skóry charakteryzujących się wysiękiem białek surowicy
DE602004019528D1 (de) Usammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
BRPI0506699A (pt) método para lavar aves domésticas durante o processamento com composições de ácido peroxicarboxìlicos de cadeias médias
TW200715961A (en) Herbicide composition
WO2008023003A8 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
ZA200805598B (en) Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
EP1782794A3 (de) Wasserfreie Zusammensetzung, ein Säure-Säure-Puffersystem enthaltend